These aforementioned findings demonstrated a novel relationship between PDZK1, Akt, Her2/Neu, EGFR and Cdc37 in breast cancer unraveling a new axis that can be targeted therapeutically to reduce the burden of human breast cancer. Here, ERBB2 is linked to breast carcinoma.